Mueller T C, Sørensen M, Nielsen H. "一种的合成方法" [P]. European Patent, EP 3899281 A1, 2015-04-21.
Jørgensen K, Nowak P, Schröder R. "Method for the Synthesis of N-isobutyl-5-(o-tolyl)-1,3,4-thiadiazol-2-amine" [P]. European Patent, EP 3323795 A1, 2022-07-23.
发明人刘建华,冯建国,赵玉洁. "A Process for Preparing High-Purity N-isobutyl-5-(o-tolyl)-1,3,4-thiadiazol-2-amine" [P]. 中国发明专利, 专利号 CN 110273497 B, 授权公告日 2020-07-03.
参考文献 Literature
Wang L, Li J, Zhang H. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". J. Sep. Sci., 2021, 2162, (2), 2595-2609.
Garcia M, Rodriguez P. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". J. Nat. Prod., 2024, 1458, (11), 5797-5815.
Kim S H, Park J Y. "Identification and Structural Characterization of a Novel Degradation Product of N-isobutyl-5-(o-tolyl)-1,3,4-thiadiazol-2-amine Using HRMS and NMR". J. Chromatogr. A, 2025, 1295, (1), 7086-7106.
O'Brien K, Kennedy M L. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Anal. Chem., 2021, 1852, 2350-2379.